News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Matasar_Matthew_MD_NJ_web.jpg)
MCL: Event-free survival at 2 years bodes well
- Author:
- Andrew D. Bowser
With current therapies, patients who achieve 24 months of event-free survival live almost as long as the general population.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Brown_Jennifer_R_BOST_ASH_web.jpg)
CLL phase 3 study: Zanubrutinib bests ibrutinib
- Author:
- Andrew D. Bowser
The second-generation Bruton’s tyrosine kinase inhibitor zanubrutinib outperformed ibrutinib in a phase 3 study.
News
Transplant provides no clear survival benefit in real-world MCL study
- Author:
- Andrew D. Bowser
The findings apparently contradict the survival benefit seen in clinical trial data, authors said, but are consistent with other recent...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Grimelius_Ingrid_SWEDEN_web.jpg)
Blame MCL, not transplantation, for late effects?
- Author:
- Andrew D. Bowser
In patients with mantle cell lymphoma, long-term complications appeared to be caused by the disease itself, not by intensive therapy.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Ferraro_Simone_ITALY_web2.jpg)
Phase 3 trial yields better way to predict MCL outcomes
- Author:
- Andrew D. Bowser
In a phase 3 trial of mantle cell lymphoma outcomes, repeated evaluations of minimal residual disease over time improved prognostic power.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/El Rassi_MD_GA_web.jpg)
Telemedicine helps SCD patients survive COVID, but more need access
- Author:
- Andrew D. Bowser
The second COVID-19 wave brought zero deaths and fewer complicated hospitalizations at the largest U.S. adult sickle cell disease center, but care...
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/155152_SS2763520_web.jpg)
Mesothelioma trials: Moving toward improved survival
- Author:
- Andrew D. Bowser
New and emerging therapeutic developments hold the promise of extending survival for select patients.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Dilling_Daniel_IL_web.jpg)
Genomic classifier is one piece of the ILD diagnosis puzzle
- Author:
- Andrew D. Bowser
Genomic testing increases confidence and consensus, but can’t be used in a vacuum, speaker says.
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Ghattas_Christian_OHIO_web.jpg)
Novel bronchoscopic interventions appear promising for patients with COPD
- Author:
- Andrew D. Bowser
The latest bronchoscopic interventions under investigation could be a “breath of fresh air” for patients with...
News
Fungal infection can mimic lung cancer metastases
- Author:
- Andrew D. Bowser
Investigations of concerning head lesions led to a suspicious chest mass, prompting an eventual correct...
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Life-threatening paradoxical bronchospasm may escape recognition in patients with COPD or asthma
- Author:
- Andrew D. Bowser
Greater recognition and more education is needed, according to an investigator who conducted a study of spirometry tests at a VA medical center....
News
![](https://cdn-uat.mdedge.com/files/s3fs-public/styles/max_width_small/public/Bacharier_Leonard_TENN_web.png)
Dupilumab-improved lung function lasts in children with moderate to severe asthma
- Author:
- Andrew D. Bowser
Add-on treatment yielded significant improvements over 52 weeks in children with the type 2 phenotype, the most...
News
9-step ladder may kids with allergies return to eggs
- Author:
- Andrew D. Bowser
Attempts to reintroduce egg into the child’s diet can start at the age of 12 months or 6 months from the last reaction.
News
Polyethylene glycol linked to rare allergic reactions seen with mRNA COVID-19 vaccines
- Author:
- Andrew D. Bowser
In the mRNA COVID-19 vaccines, PEG serves to stabilize the lipid nanoparticles that help...
News
![](https://qa00.mdedge.com/sites/all/modules/contrib/lazyloader/image_placeholder.gif)
Refined heart rate cutoffs may improve prognostic value of acute PE scoring systems
- Author:
- Andrew D. Bowser
In an observational registry-based study, dropping the 110-bpm heart rate threshold improved sensitivity for low-risk PE, while increasing it...